Higher employer-sponsored healthcare premiums were found to occur in companies where women account for 75% or more, as opposed to 25%, of the workforce, according to a statistical brief.
Higher employer-sponsored healthcare premiums were found to occur in companies where women account for 75% or more, as opposed to 25%, of the workforce, according to a statistical brief from the Agency for Healthcare Research and Quality.
The statistical brief reported estimates of private sector employer-sponsored health insurance (ESI) premiums (single, employee-plus-one, family), employee contributions by firm size, and the percentage of an establishment’s workforce who are women. As women aged 19 to 64 have higher medical expenditures than men of the same age, the researchers sought to investigate whether private sector ESI premiums mirror these prices:
The results showed that in companies where women accounted for 75% or more of the workforce, ESI premiums averaged $7233 for single coverage, as opposed to $6400 in companies where women account for 25% of the workforce. These statistics were based off companies who had 50 or more employees, and were similar to the overall average single premiums (75% or more of women overall: $7170; 25% or less of women overall: $6432).
In analyses on ESI average premiums for employee-plus-one and family health plans, both exhibited higher overall average premiums in establishments with 75% or more of women in the workforce, compared to 25% or less (employer-plus-one: $13,942 vs $13,050; family: $20,593 vs $18,875). When accounting for companies with 50 or more employees, disparities in ESI premiums for workforces with 75% of women, compared to 25%, increased (employer-plus-one: $14,079 vs $13,115; family: $20,908 vs $19,134).
There were no statistically significant differences found in average ESI single employee contributions by percentage of women in the workforce overall, or by firm size. For ESI average employee contributions to employee-plus-one health plans, averages were found least in establishments with 25% to 49% of women in the workforce in both overall companies ($3371), and those with 50 employees or more ($3325). In ESI average employee contributions to family health plans, averages were highest in workforces with 75% or more of women in both overall companies ($5963), and those with 50 employees or more ($5960).
Reference
Premiums and employee contributions to employer-sponsored health insurance by workforce gender and firm size, private industry, 2018. Statistical Brief #525. Agency for Healthcare Research and Quality website. https://meps.ahrq.gov/data_files/publications/st525/stat525.shtml? Published September 2019. Accessed October 17, 2019.
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
October 31st 2024As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Prescription Rebate Guarantees: Employer Insights
July 19th 2024This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
October 31st 2024As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design
August 31st 2021On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Listen
Prescription Rebate Guarantees: Employer Insights
July 19th 2024This study examined employers’ understanding of rebate guarantees, dependency upon rebate dollars, and the role that pharmaceutical rebates or employer benefits consultants play in their pharmacy benefits manager selection.
Read More
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
2 Commerce Drive
Cranbury, NJ 08512